Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival

Objectives The advent of the tyrosine kinase inhibitors has markedly changed the prognostic outlook for patients with Ph + and/or BCR-ABL1 + chronic myeloid leukemia (CML). This study was designed to assess the overall survival (OS) of Nigerian patients with CML receiving imatinib therapy and to ide...

Full description

Bibliographic Details
Main Authors: Anthony A. Oyekunle, Muheez A. Durosinmi, Ramoni A. Bolarinwa, Temilola Owojuyigbe, Lateef Salawu, Norah O. Akinola
Format: Article
Language:English
Published: SAGE Publishing 2016-01-01
Series:Clinical Medicine Insights: Blood Disorders
Online Access:https://doi.org/10.4137/CMBD.S31562

Similar Items